I’m particularly proud of the university that I went to for developing “the first and only preventative HIV vaccine based on a genetically modified killed whole virus.”
The vaccine “has received approval by the United States Food and Drug Administration (FDA) to start human clinical trials.
Developed by Dr. Chil-Yong Kang and his team at The University of Western Ontario, with the support of Sumagen Canada, the vaccine (SAV001) holds tremendous promise, having already proven to stimulate strong immune responses in preliminary toxicology tests with no adverse effects or safety risks. It is the only HIV vaccine currently under development in Canada, and one of only a few in the world.
“FDA approval for human clinical trials is an extremely significant milestone for our vaccine, which has the potential to save the lives of millions of people around the world by preventing HIV infection,” says Kang, a researcher and professor at Western’s Schulich School of Medicine And Dentistry.
Western President Amit Chakma says, “This joint venture between Sumagen and Western is a prime example of what collaboration between private industry and university researchers can achieve. Dr. Kang and his team are to be commended for their exceptional talent and remarkable persistence in developing a vaccine that addresses a tragic health crisis affecting millions of people around the globe.”
Check out a short video on the milestone below (via The University of Western Ontario) and more information on Western is available here:
www.youtube.com/westernuniversity
www.facebook.com/theuniversityofwesternontario
–
Ajani Charles
a j a n i photography: digital image solutions
www.ajani.ca
www.ajaniphotography.com
No Comments
Trackbacks/Pingbacks